Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 5, 2021
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headacheUmberto Pensato, Carlo Baraldi, Valentina Favoni, et al.The Journal of Headache and Pain|March 15, 2019
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?Valentina Favoni, Luca Giani, Linda Al-Hassany, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 21, 2024
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapyUmberto Pensato, Federica Pondrelli, Chiara de Philippis, et al.Annals of Clinical and Translational Neurology|May 18, 2022
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levelsIlaria Cani, Luisa Sambati, Fiorina Bartiromo, et al.Journal of Neurology|April 25, 2025
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapyFederica Pondrelli, Lorenzo Muccioli, Federico Mason, et al.Journal of Neurology|March 4, 2023
CAR t-cell therapy in BOlogNa-NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON-NEUTRAL): proposed protocol and results from an Italian studyUmberto Pensato, Giulia Amore, Lorenzo Muccioli, et al.The Journal of Clinical Investigation|June 4, 2024
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cellsGianluca Storci, Francesco De Felice, Francesca Ricci, et al.Neurology|August 12, 2021
Frequency and Characterization of Movement Disorders in Anti-IgLON5 DiseaseCarles Gaig, Yaroslau Compta, Anna Heidbreder, et al.Pageof 2